Skip to main content
AMNAMN Healthcare Services IncSell4.6·$46.72
SellModerate Confidence
Investment thesis

AMN's exceptional revenue growth and solid recent earnings execution stand out, but a quality score below the required threshold, overbought momentum, and bearish insider selling warrant caution.

Thesis pillars

  • Industry Leading Revenue Growth→Stable
  • Quality Below Required Floor↓Deteriorating
  • Overbought Momentum Condition↓Deteriorating
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 5, 2026, based on the 10-K filed Feb 20, 2026

Full reasoning →

Open full analysis

AMN Healthcare Services Inc (AMN) Stock Analysis

SellVALUE-TRAP 1/5ValueModerate Confidence

Healthcare · Medical Care Facilities

Earnings in 7 days (2026-11-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Analyst target reached at $46.72 — A.R:R is negative (-2.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings expected to decline ~65% (cyclical peak).

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise... Read more

$46.72-31.9% A.UpsideScore 4.6/10#33 of 35 Medical Care Facilities
QualityF-score5 / 9FCF yield24.64%
Stop $43.45Analyst target $31.82(reached)A.R:R -2.1:1
Analyst consensus$36.57-21.7%7 analysts
$46.72price
$36.57mean
$28

Sell if holding. Analyst target reached at $46.72 — A.R:R is negative (-2.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings expected to decline ~65% (cyclical peak). Chart setup: No clear chart pattern; technical signals are mixed. Score 4.6/10, moderate confidence.

Passes 5/8 gates (positive momentum, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 7d<=7d. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29

Recent Developments — AMN Healthcare Services Inc

Generated 2026-10-29T11:48:39Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 5, 20267d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Risks
Earnings expected to decline ~65% (cyclical peak)
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1)

Key Metrics

P/E (TTM)17.4
P/E (Fwd)49.8
Mkt Cap$1.8B
EV/EBITDA7.2
Profit Mgn3.1%
ROE15.6%
Rev Growth2.3%
Beta0.40
DividendNone
Rating analysts13

Quality Signals

Piotroski F5/9

Options Flow

P/C2.40bearish
IV80%elevated

Concentration Risks(10-K Item 1A)

  • LOWCustomerKaiser Foundation Hospitals22%
    10-K Item 1A: 'Kaiser Foundation Hospitals (and its affiliates) (collectively, “Kaiser”) comprised approximately 22% of our consolidated revenue in 2025.'

Material Events(8-K, last 90d)

  • 2026-05-04Item 5.02LOW
    Shareholders approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan at the May 1, 2026 Annual Meeting, previously approved by the Board subject to shareholder vote. Routine compensatory plan item; no officer or director departure involved.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.1
Low model confidence on this dimension (33%).
GatesA.R:R -2.1=NEGATIVEEARNINGS PROXIMITY 7d<=7dExecutive change: officer departure/appointmentMomentum 5.5>=5.5Insider activity: OKNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
85 · Overbought
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $34.61Resistance $49.62

Price Targets

A.Upside-31.9%
A.R:R-2.1:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Cyclical trap - fwd PE 50x vs trail 17x (2.9x)
! Target reached (-31.9% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-05 (7d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AMN stock a buy right now?

Sell if holding. Analyst target reached at $46.72 — A.R:R is negative (-2.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings expected to decline ~65% (cyclical peak). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $43.45. Score 4.6/10, moderate confidence.

What is the AMN stock price target?

Analyst target $31.82 reached (−31.9% from $46.72); no take-profit level is published. Prior stop was $43.45. Stop-loss: $43.45.

What are the risks of investing in AMN?

Earnings expected to decline ~65% (cyclical peak); Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1).

Is AMN overvalued or undervalued?

AMN Healthcare Services Inc trades at a P/E of 17.4 (forward 49.8). TrendMatrix value score: 4.9/10. Verdict: Sell.

What do analysts say about AMN?

13 analysts cover AMN with a consensus score of 3.5/5. Average price target: $37.

What does AMN Healthcare Services Inc do?AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering...

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise platform and AMN Passport app (340,000+ users). The company had 2,664 corporate team members as of December 31, 2025 and averaged about 8,722 nurses/allied professionals in Q4 2025, with Kaiser Foundation Hospitals its largest client at approximately 22% of 2025 consolidated revenue.

Related stocks: SRTA (Strata Critical Medical, Inc.) · ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · CHE (Chemed Corp) · STLN (Starling Oncology, Inc.)
Home › Stocks › AMN

Latest news

Latest News

Fiscal.ai10d ago
Benzinga20d ago
Benzinga76d ago
Benzinga83d agoAnalyst
Benzinga84d ago
Benzinga84d agoEarnings
Benzinga84d ago
Benzinga99d agoAnalyst